Cytokinetics Inc vs United Microelectronics Corp — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while United Microelectronics Corp trades at $19.58 (market cap $47.81B). The key difference: United Microelectronics Corp is far larger — about 4.5× Cytokinetics Inc's market cap, and United Microelectronics Corp pays a 2.12% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | UMC | |
|---|---|---|
Market Cap | $10.63B | $47.81B |
Sector | Technology | Technology |
52-Week High | $87.26 | $28.02 |
52-Week Low | $34.31 | $6.58 |
Enterprise Value | $10.74B | $44.93B |
Dividend Yield | — | 2.12% |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →